Nrf3-Trim5轴在血管光滑肌肉细胞功能障碍和新极度增生症中的新型作用
Qishan Chen1,2, Shasha Sun1, Zhenning Shi1,2
1Department of Cardiology, Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, China.
Cardiovascular research
|May 16, 2025
概括
核因素红色素2相关因子3 (Nrf3) 通过激活Trim5基因,促进血管光滑肌细胞 (VSMC) 功能障碍和动脉重塑,驱动新极度增生症 (NIH). 抑制这种Nrf3-Trim5通路为血管疾病提供了一种新的治疗策略.
科学领域:
- 血管生物学 血管生物学
- 分子医学是分子医学.
- 细胞信号传输 细胞信号传输
背景情况:
- 新极性增生症 (NIH) 是血管疾病 (如动脉样硬化和静脉缩) 中的一个关键病理过程,经常导致缺血性并发症.
- 血管光滑肌细胞 (VSMC) 功能障碍是NIH的核心,但治疗目标仍然有限.
- 核因子红色素2相关因子3 (Nrf3) 已涉及VSMC分化,但其在NIH中的作用基本上是未知的.
研究的目的:
- 调查Nrf3在VSMC功能障碍和NIH引起的损伤中的功能作用.
- 阐明Nrf3在血管改造中的作用背后的分子机制.
- 评估在NIH中准Nrf3通路的治疗潜力.
主要方法:
- 在人类动脉样和转录组数据集中对Nrf3表达的分析.
- 全球 (Nrf3-/-) 和VSMC特定 (Nrf3ΔSMC) Nrf3淘汰赛小鼠模型的生成和利用.
- 分子分析以确定Nrf3下游目标和调节途径.
- 评估Nrf3抑制在一个猪大动脉支架模型的血管改造.
主要成果:
- 人类动脉样硬化血管中Nrf3表达升高,与NIH正相关.
- 细胞内膜网膜 (ER) 的压力会通过ATF4.4诱导Nrf3的表达.
- Nrf3促进VSMC的增殖,迁移和炎症;它的缺失减轻了受伤引起的NIH.
- Nrf3上调调节三方动机含有5 (Trim5) 的表达,增强自和促进VSMC功能障碍.
- 在淘汰赛小鼠中恢复 Nrf3 或 Trim5 挽救的动脉表型.
- 在猪模型中,Nrf3抑制显著降低了缩.
结论:
- Nrf3是VSMC功能障碍和NIH引起的损伤的关键调解者.
- Nrf3通过转录激活Trim5来促进NIH,Trim5驱动自和血管重塑.
- 针对Nrf3-Trim5信号轴为NIH相关的血管疾病提供了一个有前途的治疗策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Nitric Oxide Signaling Pathway
4.9K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.9K
Antihypertensive Drugs: Vasodilators
440
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
440


